Could cause temporary or reversible harm; serious harm is unlikely.
Product Mix-Up: a complaint received indicating mix-up of 10 mg Lisinopril tablets inside of 2 sealed bottles of 20 mg/1000 count bottles.
| Distributed by / for | Lupin Pharmaceuticals, Inc. Baltimore MD 21202 |
| NDC | 68180-0981-03 |
| Full product label | Lisinopril Tablets USP, 20 mg, 1000-count bottle, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore MD 21202, Manufactured by: Lupin Limited Pithampur (M.P.) 454 775, India. NDC 68180-0981-03 |
| Recalling firm | Lupin Pharmaceuticals Inc. |
| Distribution | Product was distributed Nationwide in the United States. |
| Quantity | 11,808 bottles |
| Recall initiated | 2020-04-20 |
| Report date | 2020-04-29 |
| Recall completed | 2021-06-07 |
| Recall number | D-1250-2020 |
| Classification | Class II |
| FDA status | Terminated |
| Origin on file | Baltimore MD United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗